Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease

Neurobiology of Disease

Volumn 15, Issue 2, 2004, Pages 361-370

  Wang, Hung Li ^a   Chang, Wen Teng ^a   Yeh, Tu Hsueh ^b   Wu, Tony ^b   Chen, Mei Shin ^a   Wu, Ching Yi ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Connexin 32; Gap junction; Junctional conductance; N2A cells; Tracer coupling; X linked dominant Charcot Marie Tooth disease

Indexed keywords

CONNEXIN 32; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; GAP JUNCTION; HEREDITARY MOTOR SENSORY NEUROPATHY; MUTANT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; X CHROMOSOME LINKED DISORDER;

AMINO ACID SUBSTITUTION; ANIMALS; AXONS; CELL MEMBRANE; CELLS, CULTURED; CHARCOT-MARIE-TOOTH DISEASE; CONNEXINS; DEMYELINATING DISEASES; GAP JUNCTIONS; GENES, DOMINANT; GENETIC DISEASES, X-LINKED; HUMANS; ION CHANNELS; MEMBRANE POTENTIALS; MICE; MUTATION; PATCH-CLAMP TECHNIQUES; SCHWANN CELLS;

EID: 1542270715     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.11.005     Document Type: Article

References (47)

1. Abrams C.K., Oh S., Ri Y., Bargiello T.A. Mutations in connexin 32: the molecular and biophysical bases for the X-linked Charcot-Marie-Tooth disease. Brain Res. Rev. 32:2000;203-214.
2. Abrams C.K., Freidin M.M., Verselis V.K., Bennett M.V.L., Bargiello T.A. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked Charcot-Marie-Tooth disease. Brain Res. 900:2001;9-25.
3. Abrams C.K., Bennett M.V.L., Verselis V.K., Bargiello T.A. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease. Proc. Natl. Acad. Sci. U.S.A. 99:2002;3980-3984.
4. Altevogt B.M., Kleopa K.A., Postma F.R., Scherer S.S., Paul D.L. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J. Neurosci. 22:2002;6458-6470.
5. Anzini P., Neuberg D.H., Schachner M., Nelles E., Willecke K., Zielasek J., Toyka K., Suter U., Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin32. J. Neurosci. 17:1997;4545-4561.
6. Balice-Gordon R.J., Bone L.J., Scherer S.S. Functional gap junctions in the Schwann cell myelin sheath. J. Cell Biol. 142:1998;1095-1104.
7. Bergoffen J., Trofatter J., Pericak-Vance M.A., Haines J.L., Chance P.F., Fischbeck K.H. Linkage localization of X-linked Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 52:1993;312-318.
8. Bergoffen J., Scherer S.S., Trofatter J., Wang S., Oronzi Scott M., Bone L.J., Paul D.L., Cehn K., Lensh M.W., Chance P.F., Fischbeck K.H. Connexin mutation in X-linked Charcot-Marie-Tooth disease. Science. 262:1993;2039-2042.
9. Bone L.J., Dahl N., Lensch M.W., Chance P.F., Kelly T., Le Guern E., Magi S., Parry G., Shapiro H., Wang S., Fischbeck K.H. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease. Neurology. 45:1995;1863-1866.
10. Bone L.J., Deschenes S.M., Balice-Gordon R.J., Fischbeck K.H., Scherer S.S. Connexin32 and X-linked Charcot-Marie-Tooth disease. Neurobiol. Dis. 4:1997;221-231.
11. Bruzzone R., White T.W., Scherer S.S., Fischbeck K.H., Paul D.L. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron. 13:1994;1253-1260.
12. Bruzzone R., White T.W., Paul D.L. Connections with connexins: the molecular basis of direct intercellular signaling. Eur. J. Biochem. 238:1996;1-27.
13. Castro C., Gomez-Hernandez J.M., Silander K., Barrio L. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J. Neurosci. 19:1999;3752-3760.
14. Corcos I.A., Lafreniere R.G., Begy C.R., Loch-Caruso R., Willard H.F., Glover W. Refined localization of human connexin32 gene locus, GJB1, to Xql3.1. Genomics. 13:1992;479-480.
15. Dermietzel R., Spray D.C. From Neuro-Glue to glia: a prologue. Glia. 24:1998;1-8.
16. Deschenes S.M., Walcott J.L., Wexler T.L., Scherer S.S., Fischbeck K.H. Altered trafficking of mutant connexin32. J. Neurosci. 17:1997;9077-9084.
17. Dubourg O., Tardieu S., Birouk N., Gouider R., Leger J.M., Maisonobe T., Brice A., Bouche P., Le Guern E. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain. 124:2001;1958-1967.
18. Fairweather N., Bell C., Cochrane S., Chelly J., Wang S., Mostaciuolo M.L., Monaco A.P., Haites N.E. Mutations in the connexin 32 gene in X-linked Charcot-Marie-Tooth disease. Hum. Mol. Genet. 3:1994;29-34.
19. Fischbeck K.H., Abel A., Lin G.S., Scherer S.S. X-linked Charcot-Marie-Tooth disease and connexin32. Ann. N.Y. Acad. Sci. 883:1999;36-41.
20. Goodenough D.A., Goliger J.A., Paul D.L. Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 64:1996;475-502.
21. Ionasescu V.V., Searby C., Ionasescu R. Point mutations of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Hum. Mol. Genet. 3:1994;335-358.
22. Ionasescu V.V., Searby C., Ionasescu R., Meschino W. New point mutations and deletions of the connexin 32 gene in X-linked Charcot-Marie-Tooth neuropathy. Neuromuscular Dis. 5:1995;297-299.
23. Janssen E.A.M., Kemp S., Hensels G.W., Sie O.G., de Die-Smulders C.E.M., Hoogendijk J.E., de Visser M., Bolhuis P.A. Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth disease. Hum. Genet. 99:1997;501-505.
24. Kleopa K.A., Yum S.W., Scherer S.S. Cellular mechanisms of connexin32 mutations associated with CNS manifestations. J. Neurosci. Res. 68:2002;522-534.
25. Kojima T., Kokai Y., Chiba H., Yamamoto M., Mochizuki Y., Sawada N. Cx32 but not Cx26 is associated with tight junctions in primary cultures of rat hepatocytes. Exp. Cell Res. 263:2001;193-201.
26. Kumar N.M., Gilula N.B. Cloning and characterization of human and rat liver cDNAs encoding for a gap junction protein. J. Cell Biol. 103:1986;767-776.
27. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell. 84:1996;381-388.
28. Martin P.E.M., Mambetisaeva E.T., Archer D.A., George C.H., Evans W.H. Analysis of gap junction assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease. J. Neurochem. 74:2000;711-720.
29. Matsuyama W., Nakagawa M., Moritoyo T., Takashima H., Umehara F., Hirata K., Suehara M., Osame M. Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant connexin-32. J. Hum. Genet. 46:2001;307-313.
30. Oh S., Ri Y., Bennett M.L., Trexler E.B., Versalis V.K., Bargiello T.A. Changes in permeability caused by connexin 32 mutations underlies X-linked Charcot-Marie-Tooth disease. Neuron. 19:1997;927-938.
31. Omori Y., Mensil M., Yamasaki H. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol. Biol. Cell. 7:1996;907-916.
32. Paul D.L. Molecular cloning of cDNA for rat liver gap junction protein. J. Cell Biol. 103:1986;123-134.
33. Peracchia C., Sotkis A., Wang X.G., Peracchia L.L., Persechini A. Calmodulin directly gates gap junction channels. J. Biol. Chem. 275:2000;26220-26224.
34. Rabadan-Diehl C., Dahl G., Werner R. A connexin-32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett. 351:1994;90-94.
35. Ressot C., Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked Charcot-Marie-Tooth disease. Brain Res. Rev. 32:2000;192-202.
36. Ressot C., Gomes D., Dautigny A., Pham-Dinh D., Bruzzone R. Connexin 32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties. J. Neurosci. 18:1998;4063-4075.
37. Rozental R., Morales M., Mehler M.F., Urban M., Marion K., Dermietzl R., Kessler J.A., Spray D.C. Changes in the properties of gap junctions during neuronal differentiation of hippocampal progenitor cells. J. Neurosci. 18:1998;1753-1762.
38. Scherer S.S. Molecular genetics of demyelination: new wrinkles on an old membrane. Neuron. 18:1997;13-16.
39. Scherer S.S., Deschenes S.M., Xu Y.T., Grinspan J.B., Fischbeck K.H., Paul D.L. Connexin-32 is myelin-related protein in the PNS and CNS. J. Neurosci. 15:1995;8281-8294.
40. Scherer S.S., Xu Y.T., Nelles E., Fischbeck K.H., Willcke K., Bone L.J. Connexin32 null mice develop demyelinating peripheral neuropathy. Glia. 24:1998;8-20.
41. Simon A.M., Goodenough D.A. Diverse functions of vertebrate gap junctions. Trends Cell Biol. 8:1998;477-483.
42. Spray D.C., Dermietzel R. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system. Trends Neurosci. 18:1995;156-262.
43. Tan C.C., Ainsworth P.J., Hahn A.F., MacLeod P.M. Novel mutations in the connexin 32 gene associated with X-linked Charcot-Marie-Tooth disease. Hum. Mutat. 7:1996;167-171.
44. Wang H.L. A conserved arginine in the distal third intracellular loop of the μ-opioid receptor is required for G protein activation. J. Neurochem. 72:1999;1215-1222.
45. Wang H.L., Wu T., Chang W.T., Li A., Chen M.S., Wu C.Y., Fang W. Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene. Mol. Brain Res. 78:2000;146-153.
46. Wang H.L., Chang W.T., Li A., Yeh T.H., Wu C.Y., Chen M.S., Huang P.C. Functional analysis of connexin-26 mutants associated with hereditary recessive deafness. J. Neurochem. 84:2003;735-742.
47. Yoshimura T., Satake M., Ohnishi A., Tsutsumi Y., Fujikura Y. Mutations of connexin 32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression. J. Neurosci. Res. 51:1998;154-161.